Glycotope to Spin-out Its Service Business to the Newly Formed FyoniBio GmbH
As of February 1, 2022, the service business previously operated by Glycotope GmbH is now part of the newly established FyoniBio GmbH. Under the umbrella of the Canton Biologics Group, FyoniBio will continue to offer a broad portfolio of ISO-9001 compliant services — from cell line development to GCLP-compliant clinical bioanalysis — with the same team, labs, and location. With expanded capabilities and strong new backing, FyoniBio looks forward to supporting both existing and new partners with the same scientific reliability and tailored approach.
